Showing results (1261-1270 of 2,285) with videos related to

Sort By:
Pageof 229
HIV Medicine|March 20, 2014
The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovirJ Young, Q Wang, C A Fux, et al.
HIV Medicine|March 4, 2014
European mitochondrial haplogroups are not associated with hepatitis C virus (HCV) treatment response in HIV/HCV-coinfected patientsM Guzmán-Fulgencio, N Rallón, J Berenguer, et al.
HIV Medicine|March 4, 2014
Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearanceP Ingiliz, I Krznaric, H-J Stellbrink, et al.
HIV Medicine|March 2, 2017
Does efavirenz replacement improve neurological function in treated HIV infection?B Payne, T J Chadwick, A Blamire, et al.
HIV Medicine|January 25, 2017
Fat mass and obesity-associated gene variations are related to fatty liver disease in HIV-infected patientsR Núñez-Torres, J Macías, A Rivero-Juarez, et al.
HIV Medicine|January 25, 2017
Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV-1 infectionL Calza, V Colangeli, E Magistrelli, et al.
HIV Medicine|January 25, 2017
Recreational drug use and chemsex among HIV-infected in-patients: a unique screening opportunityE R Elliot, S Singh, S Tyebally, et al.
HIV Medicine|October 8, 2016
Switching regimens in virologically suppressed HIV-1-infected patients: evidence base and rationale for integrase strand transfer inhibitor (INSTI)-containing regimensF Raffi, S Esser, G Nunnari, et al.
HIV Medicine|December 31, 2016
Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST studyE Poveda, J Hernández-Quero, M J Pérez-Elías, et al.
HIV Medicine|December 17, 2016
MicroRNA-155 is a biomarker of T-cell activation and immune dysfunction in HIV-1-infected patientsC Jin, L Cheng, S Höxtermann, et al.
Pageof 229